Open Memuplay website by clicking this link - Download Memuplay Emulator.
Double-click the app icon to open and use the BlueSense in your favorite Windows PC or Mac.īlueSense Download for PC Windows 7/8/10 – Method 2: Once the installation is over, you will find the BlueSense app under the "Apps" menu of BlueStacks.Click "Install" to get it installed. Always make sure you download the official app only by verifying the developer's name. Now you can search Google Play store for BlueSense app using the search bar at the top.On the home screen, double-click the Playstore icon to open it. BlueStacks comes with Google play store pre-installed.You will see the home screen of Bluestacks. Just be patient until it completely loads and available. It may take some time to load for the first time. Once the installation is complete, open the BlueStacks software.Installation is as simple and easy as any other software installation.
The global distribution and burden of dengue. 2013 30(3):1–21.īhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. Field evaluation and impact on clinical management of a rapid diagnostic kit that detects dengue NS1, IgM and IgG. False-negative dengue cases in Roraima, Brazil: an approach regarding the high number of negative results by NS1 ag kits. Our results also suggest that Dengue virus (DENV) viral load estimated through the RT-qPCR and antibody level measured through the MAC-ELISA could have had a direct influence on the accuracy of the rapid test.Īcosta POA, Granja F, Meneses CA, Nascimento IAS, Sousa DD, Lima WP, Júnior, et al. Therefore, the test is useful in confirming the diagnosis of dengue, but not enough to rule out the diagnosis. The present phase III, large-scale validation study demonstrates that the rapid test SD Bioeasy Dengue Duo has moderate sensitivity (NS1/IgM combined) and high specificity. The reliability of the test (NS1/IgM combined) demonstrated crude agreement of 98% (Kappa index 0.94). The positive likelihood ratio was 46, and the negative likelihood ratio was 0.24. The sensitivity for the NS1 component (67%) was better than that for the IgM component (35%). The results for the overall accuracy of the rapid test (NS1/IgM combined) showed 76% sensitivity and 98% specificity. The evaluation was conducted prospectively under field conditions in the public health units of the FD. The reference standard used was a composite of MAC-ELISA, virus isolation and real-time polymerase chain reaction (RT-qPCR). Two hundred and six positive samples (cases) and 246 negative samples (non cases) were required for sensitivity and specificity estimation, respectively for agreement evaluation, we used 401 samples. In total, 1353 venous blood samples were collected between 20. To estimate the accuracy and reliability of the SD Bioeasy Dengue Duo rapid test and its components to detect dengue infections in a consecutive sample of symptomatic residents in the FD, Brazil. In this context, we decided to evaluate a rapid test introduced in the Federal District (FD). Most of those tests have not undergone validation in the Brazilian population. Early diagnosis is of great interest, and point-of-care rapid tests have been increasingly used in Brazil. However, this has changed with the newly available immunochromatographic rapid tests. Until recently, only specialised laboratories were able to confirm dengue infection.